CLASS II Drug recall · Reported 1 Mar 2023 · FDA Enforcement Report

0.9% Sodium Chloride Injection, USP Excel Plus Container recalled

B. Braun Medical is recalling 0.9% Sodium Chloride Injection, USP Excel Plus Container, distributed nationwide in the US. The recall was initiated on 10 Feb 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLots: 0061794230 Exp. 01/31/2024; 0061794232 Exp. 01/31/2024; 0061797779 Exp. 02/29/2024; 0061797780 Exp. 02/29/2024; 0061797781 Exp. 02/29/2024; 0061797783 Exp. 02/29/2024; 0061797784 Exp. 03/31/2024; 0061797785 Exp. 03/31/2024; 0061797786 Exp. 03/31/2024; 0061797787 Exp. 03/31/2024; 0061797788 Exp. 03/31/2024; 0061809680 Exp. 04/30/2024
NDC0264-5802, 0264-5804
Quantity recalled483,229 bags

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0347-2023
FDA event ID
91658
Recalling firm
B. Braun Medical, Daytona Beach, FL
Manufacturer
B. Braun Medical Inc.
Classification
Class II
Status
Completed
Recall initiated
10 Feb 2023
FDA classified
23 Feb 2023
Reported
1 Mar 2023
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility

Timeline

10 Feb 2023Recall initiated by company
23 Feb 2023Classified by FDA+13 days
1 Mar 2023Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Lack of sterility assurance: Recall of certain batches of 0.9% Sodium Chloride for Injection USP in EXCEL¿ Plus IV Container product due to the possibility of an incomplete seal that may cause leakage. The impacted lots may exhibit microscopic channel leaks near the port assembly of the product.

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

0.9% Sodium Chloride Injection, USP, 500 mL Excel Plus Container, Rx Only, B. Braun Medical Inc. Bethlehem, PA 18018, NDC 0264-5802-10

Where it was distributed

USA Nationwide.

Nationwide

Questions about this recall

Why was it recalled?

Lack of sterility assurance: Recall of certain batches of 0.9% Sodium Chloride for Injection USP in EXCEL¿ Plus IV Container product due to the possibility of an incomplete seal that may cause leakage. The impacted lots may exhibit microscopic channel leaks near the port assembly of the product.

Which lots are affected?

Lots: 0061794230 Exp. 01/31/2024; 0061794232 Exp. 01/31/2024; 0061797779 Exp. 02/29/2024; 0061797780 Exp. 02/29/2024; 0061797781 Exp. 02/29/2024; 0061797783 Exp. 02/29/2024; 0061797784 Exp. 03/31/2024; 0061797785 Exp. 03/31/2024; 0061797786 Exp. 03/31/2024; 0061797787 Exp. 03/31/2024; 0061797788 Exp. 03/31/2024; 0061809680 Exp. 04/30/2024

Where was it sold?

USA Nationwide.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 91658
ReportedClassRecallCompanyReasonWhere
CLASS II0.9% Sodium Chloride Injection, USP Excel Plus Container recalledSodium ChlorideB. Braun MedicalSterilityNationwide

More recalls from B. Braun Medical

All 447

Other Sodium Chloride recalls

All 133